WebNews

Please enter a web search for web results.

NewsWeb

Investor's Business Daily
investors. com > news > technology > veradermics-ipo-stock-oral-rogaine

How This Biotech Is Taking A Page Out Of Rogaine's Playbook

1+ day, 15+ hour ago  (302+ words) How This Biotech, Up 25%, Is Taking A Page Out Of Rogaine's Playbook'Investor's Business Daily Veradermics' (MANE) oral version of Rogaine led to "rapid and robust hair growth" for men with pattern hair loss, the company said Monday. The recent IPO…...

Investor's Business Daily
investors. com > news > technology > ligand-stock-xoma-stock-acquisition

Royalty Powerhouse: Biotechs Unite In $739 Million Deal

1+ day, 11+ hour ago  (298+ words) Investor's Business Daily Ligand Pharmaceuticals (LGND) snatched up Xoma Royalty (XOMA) in a deal worth $739 million, the companies said Monday as both biotech stocks jumped. The two companies are biotech royalty machines. They don't develop drugs. Instead, they help fund…...

Bio Space
biospace. com > business > altitude-labs-serves-up-higher-education-for-biotech-founders

Altitude Labs serves up higher education for biotech founders

23+ min ago  (867+ words) Carmen Kivisild presents her company Elnora, an AI agent for lab protocols, at Altitude Labs" Demo Day on April 15. This is Altitude Labs. And today is graduation day, so to speak. Once a year, Altitude hosts Demo Day, giving each…...

Sifted
sifted. eu > articles > gv-backed-omass-ip-lawsuit

GV-backed biotech startup OMass faces IP lawsuit

1+ hour, 19+ min ago  (163+ words) OMass Therapeutics, an Oxford-based biotech backed by Alphabet's venture arm GV and Oxford Science Enterprises, is being sued over an intellectual property dispute, according to court filings seen by Sifted. Maya Dharampal-Hornby is a reporter, covering UK tech for Sifted,…...

Bio Process OL
bioprocessonline. com > doc > minimizing-regulatory-risk-for-biologics-manufacturing-changes-0001

Minimizing Regulatory Risk For Biologics Manufacturing Changes

30+ min ago  (182+ words) Guest Column | April 29, 2026 By Megha Sinha, founder and CEO, Kamet Consulting Group Post-approval change management for biologics presents a very different challenge from that of manufacturers of small molecules. Here, it is not typically an issue of volume (a biologic…...

Minichart
minichart. com. sg > 04/28/2026 > pds-biotech-2025-executive-compensation-leadership-structure-and-equity-ownership-overview

PDS Biotech 2025 Executive Compensation, Leadership Structure, and Equity Ownership Overview

6+ hour, 48+ min ago  (428+ words) Minichart We value your privacy No cookies to display. Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features. Advertisement cookies are used to provide visitors with…...

Pharmaceutical Technology
pharmaceutical-technology. com-technology. com

Merck KGa A and Remepy join forces to develop combo drug-digital therapies

18+ hour, 25+ min ago  (551+ words) Merck KGa A has inked a collaboration deal with Israeli-US startup, Remepy, to explore the therapeutic potential of combination drug and app-based approaches in rare oncology " marking the first big pharma foray into this new evolving area for digital therapies....

Bio Pharma APAC
biopharmaapac. com > news > 83 > 7880 > samsung-bioepis-co-ltd-and-atlatl-innovation-center-forge-apac-open-innovation-pact-to-accelerate-early-stage-biotech-growth. html

Samsung Bioepis Co. , Ltd. And ATLATL Innovation Center Forge APAC Open Innovation Pact To Accelerate Early Stage Biotech Growth

5+ hour, 26+ min ago  (227+ words) 29 April 2026 | Wednesday | News Samsung Bioepis Co. , Ltd. and ATLATL Innovation Center (hereinafter referred to as "ATLATL"), global innovation platform for life science research and development, today announced that the companies have entered into a Memorandum of Understanding (Mo U) on an…...

Education News Canada
educationnewscanada. com > article > education > level > university > 1 > 1197515 > ai-startup-founded-by-u-of-t-alumni-to-revive-failed-drug-candidates. html

University of Toronto - AI startup founded by U of T alumni to revive failed drug candidates

1+ hour, 24+ min ago  (215+ words) UNIVERSITY OF TORONTO AI startup founded by U of T alumni to revive failed drug candidates'Education News Canada A startup founded by University of Toronto alumni has won Silicon Valley buy-in for its novel approach to AI-assisted drug development - resurrecting…...

Yahoo Finance
finance. yahoo. com > sectors > healthcare > articles > pharma-meets-ai-conference-2026-162038797. html

Pharma Meets AI Conference 2026: AI in pharma begins delivering measurable ROI

1+ day, 9+ hour ago  (20+ words) AI tools that slash time spent on administration prove their worth and free up pharma workers for higher value tasks....